/Investor DB

Canaan Partners — 2020 Investments

17 investments dated 2020 · listed companies and verified rows first · show all

Rallybio HoldingsNASDAQ: RLYBMar 2020

Rallybio is a clinical-stage biotechnology company developing therapies for severe and rare diseases, with a lead program in RLYB116, a C5 complement inhibitor in clinical development, and a preclinical program in RLYB332, a matriptase-2 antibody for iron overload disorders.

HealthtechFarmington, US

Jeffrey M. Fryer(Executive Officer, Director)Martin W. Mackay(Executive Officer, Director)Stephen Uden(Executive Officer, Director)

Board seatTimothy Shannon· per SEC Form D

Co-investors5AM VenturesPivotal Life Sciences

Iantrekiantrekmed.cominOct 2020✓ verified

Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.

BiotechHealthtechMedical DevicesElkins Park, US

Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))inMichael Haydin(Executive Officer)

BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)

Board seatStephen Bloch· per SEC Form D

Co-investorsaMoonVisionary VenturesCivilization Ventures Management, LlcFemHealth VenturesJSD Capital, LLCUS Venture Partners

Trishula Therapeutics, Inc.trishulatx.cominAug 2020✓ verified

Trishula Therapeutics is a clinical-stage biopharmaceutical company developing TTX-030, a first-in-class anti-CD39 antibody for advanced cancers.

BiotechHealthtech

Anil Singhal(President and CEO)inSiddhartha Mitra(Chief Medical Officer)in

Co-investorsMPM BioImpactAstellas Venture Management LLCLightstone Ventures

nTopologyntop.comin𝕏Jun 2020 · $65M

nTop provides a software platform for engineering design that uses implicit modeling and physics-based simulation to accelerate product development.

Advanced ManufacturingAI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareSaaSNYC, US

Gregory Schroy(Executive Officer, Director, Promoter)Bradley Rothenberg(Founder)in

Board seatHrach Simonian· per SEC Form D

Co-investorsIn-Q-TelNimble PartnersNotation CapitalNVIDIAPathbreaker VenturesRoot Ventures Manager, Llc+8 more

Sounding Boardsoundingboardinc.comin𝕏Series A · Dec 2020 · $13MAcquired

Sounding Board provides leadership development and coaching programs delivered through software, combining a global network of expert coaches with tools to build, manage, track, and measure development initiatives.

Future of WorkHR TechSaaSAliso Viejo, US

Lori Mazan(Co-founder & Chief Coaching Officer)inChristine Tao(Founder)inJessica Wolf(Founder)Lori Mazen(Founder)

Board seatMaha Ibrahim· per SEC Form D

Co-investorsBloomberg BetaGaingelsGeek VenturesJAZZ Venture PartnersTech Square VenturesAcrew Capital+1 more

TAPTAPtaptapsend.comin𝕏Series A · May 2020 · $13M

Taptap Send is a money transfer application that enables users to send remittances to over 70 destinations across Africa, Asia, the Caribbean, and Latin America at lower costs and faster speeds than traditional services.

FintechImpact & Social GoodNew York, GB

Michael Faye(Founder)inMitchell Riley(Executive Officer)Paul Niehaus(Founder)

BoardChristopher Schroeder(Director)

Board seatBrendan Dickinson· per SEC Form D

Co-investorsOmidyar NetworkBalderton CapitalBlue CollectiveBreyer CapitalFinbergFJ Labs+10 more

Transposon Therapeuticstransposonrx.comApr 2020

Transposon Therapeutics is a biotechnology company developing therapies for neurodegenerative and aging-related diseases, with a pipeline that includes its lead candidate TPN-101 and novel NRTIs targeting conditions such as PSP, ALS/FTD, and Alzheimer's disease.

BiotechHealthtechLongevitySan Diego, US

Dennis Podlesak(Executive Officer, Director)Lynne R. Rollins(Executive Officer)Eckard Weber, MD(Executive Officer, Director)Eckard Weber, M.D.(Executive Officer, Director)in

BoardDaniel Hetu, MD, MBA(Director)

Board seatBrent AhrensJohn Pacifico· per SEC Form D

Co-investorsLumira Ventures

Alkymialkymi.ioin𝕏Seed · Feb 2020 · $5M

Alkymi provides an AI-powered platform that extracts and automates data from unstructured documents, turning it into workflow-ready data via APIs.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechNew York City, US

Harald Collet(Founder)inAdam Kleczewski(Founder)

Co-investorsIntel CapitalWork-BenchEssence Venture Capital

Axis Securityaxissecurity.comSep 2020Acquired

Zero trust network access vendor whose cloud-based secure access platform was acquired by HPE in 2023.

Co-investorsBright Pixel CapitalCyberstartsEmerald Development ManagersTen ElevenSpark Capital

Hermeus Mach 5 enginehermeus.comin𝕏Series A · Oct 2020 · $16M

Hermeus is a high-speed aircraft manufacturer developing unmanned, hypersonic aircraft for defense and national security missions.

Defense TechHardwareAtlanta, US

AJ Piplica(Founder)inSkyler Shuford(Founder)inErle Glenn Case IV(Executive Officer)Anthony John Piplica(Executive Officer, Director)Michael Smayda(Founder)inGlenn Case(Founder)

Co-investorsBling CapitalBrave CapitalCircadian VenturesCrosscourt VenturesFundamental VenturesGaingels+7 more

Lily AIlily.aiinSeries A · Jan 2020 · $13M

Lily Max is an AI-powered product intelligence engine that enriches e-commerce product catalogs and optimizes them for visibility across AI-mediated shopping surfaces including Google Ads, Meta Ads, and AI discovery platforms.

AI & Machine LearningE-commerceMarketing Tech

Purva Gupta(Founder)inSowmiya Chocka Narayanan(Founder)in

Co-investorsConductive VenturesCounterpart VenturesFernbrook Capital ManagementGaingelsNew Enterprise Associates (NEA)Think+ Ventures Management, Llc+4 more

MachEyemacheye.com𝕏Oct 2020 · $4.6M

Verint offers a CX automation platform that embeds AI, automation, and analytics into contact center workflows, covering workforce engagement, quality automation, agent copilots, knowledge automation, and conversational/agentic AI.

AI & Machine LearningEnterprise SoftwareSaaS

Ramesh Panuganty(Founder)in

Co-investorsJ-VenturesPlug and Play VenturesWestWave Capital

ScaleFactorscalefactor.cominSep 2020 · $100MDefunct

Austin fintech that sold automated accounting software to SMBs, raised ~$103M, and wound down operations in 2020.

FintechAustin, US

Kurt Rathmann(Executive Officer, Director, Promoter)Kurt Rathmann, CPA(Founder)inWilliam Siegel(Director)Gary Forni(Executive Officer, Promoter)David Loia(Executive Officer, Promoter)

BoardAmos Schwartzfarb(Director)

Co-investorsMatchstick VenturesTechstarsAbstract VenturesACME CapitalBessemer Venture PartnersBroadhaven Capital Partners+12 more

Synthekinesynthekine.comin𝕏Series A · Sep 2020 · $82M

Synthekine is a clinical-stage biotechnology company using protein engineering platforms to develop cytokine-based immunotherapies designed to preserve therapeutic efficacy while avoiding toxicities linked to cytokine pleiotropy.

BiotechHealthtech

K. Christopher Garcia(Founder)Susan Molineaux(CEO)inMartin Oft(Chief Scientific Officer)inNaiyer Rizvi(Chief Medical Officer)inGregory(Chief Technical Officer)Geoff(Chief Business Officer)

Co-investorsSamsara BioCapitalThe Column GroupBain Capital Life SciencesRA CapitalTCG CrossoverDeerfield Management Company+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

OneLookReischling PressPodz

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.